Venmax Drugs & Pharmaceuticals Ltd Quarterly Result
Venmax Drugs & Pharmaceuticals Ltd
NSE: VENMAXDRUGS
Net Profit - Last Quarter
Venmax Drugs & Pharmaceuticals Ltd Quarterly Results Key Highlights
- The revenue of Venmax Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 4.04 crore as compare to the Dec '25 revenue of ₹ 1.62 crore.
- This represent the growth of 149.38% The ebitda of Venmax Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0.11 crore as compare to the Dec '25 ebitda of ₹ 0.04 crore.
- This represent the growth of 175% The net profit of Venmax Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0.11 crore as compare to the Dec '25 net profit of ₹ 0.03 crore.
- This represent the growth of 266.67%.
Venmax Drugs & Pharmaceuticals Ltd Quarterly Results Analysis
Market Price of Venmax Drugs & Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 29 Jul 2026 | 17.89 |
| 28 Jul 2026 | 17.56 |
| 27 Jul 2026 | 16.12 |
| 24 Jul 2026 | 15.94 |
| 23 Jul 2026 | 16.9 |
| 22 Jul 2026 | 17.06 |
| 21 Jul 2026 | 16.65 |
| 20 Jul 2026 | 16.74 |
| 17 Jul 2026 | 16.5 |
| 16 Jul 2026 | 16.7 |
Historical Revenue of Venmax Drugs & Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Venmax Drugs & Pharmaceuticals Ltd
Historical EBITDA of Venmax Drugs & Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Venmax Drugs & Pharmaceuticals Ltd
Historical Net Profit of Venmax Drugs & Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Venmax Drugs & Pharmaceuticals Ltd
Venmax Drugs & Pharmaceuticals Ltd News Hub
Venmax Drugs & Pharmaceuticals to conduct board meeting
Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 Au
Read more
16 Aug 24
Venmax Drugs & Pharmaceuticals standalone net profit declines 50.00% in the June 2024 quarter
Net profit of Venmax Drugs & Pharmaceuticals declined 50.00% to Rs 0.01 crore in the quarter ended J
Read more
13 Aug 24
Venmax Drugs & Pharmaceuticals to hold board meeting
Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 Au
Read more
03 Aug 24
Venmax Drugs & Pharmaceuticals to hold AGM
Venmax Drugs & Pharmaceuticals announced that the 35th Annual General Meeting (AGM) of the company w
Read more
27 Aug 24
Document
Annual Reports
N/A
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
About Venmax Drugs & Pharmaceuticals Ltd
- Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Company as 'Yenkay Medico Private Limited', on 28 September, 1998.
- The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995.
- It became a Public Limited Company on February 3, 1995 as 'Yenkey Drugs & Pharmaceuticals Limited'.
- Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs).
- At present, Company is engaged in the business of pharmaceutical products, drug intermediaries & API's etc. The Company is developing the oncology products in R&D.
FAQs for Quarterly Results of Venmax Drugs & Pharmaceuticals Ltd
What key financial metrics are included in Venmax Drugs & Pharmaceuticals Ltd's quarterly results?
When does Venmax Drugs & Pharmaceuticals Ltd announce its quarterly results?
How does Venmax Drugs & Pharmaceuticals Ltd's quarterly performance impact its stock price?
What is the impact of Venmax Drugs & Pharmaceuticals Ltd's quarterly results on dividends?
Are there any special announcements usually made during Venmax Drugs & Pharmaceuticals Ltd's quarterly results?
